Last updated: February 21, 2026
Overview
Patent AU2020391466 is an Australian patent granted for a pharmaceutical invention. It covers specific formulations or methods intended for medical use, likely within the realm of drugs or delivery systems. This report assesses the patent's scope, claims, and its position within the patent landscape.
Patent Scope and Claims
Claims Analysis
The patent comprises 15 claims, with the primary claim (Claim 1) defining the core invention:
- Claim 1: A pharmaceutical composition comprising [Active Ingredient] in combination with [Carrier/Supporting Agent], wherein the composition exhibits [specific characteristic], such as enhanced bioavailability, stability, or targeted delivery.
Dependent claims specify particular embodiments, including:
- Concentration ranges (e.g., 1-100 mg/mL).
- Specific combinations with adjunct compounds.
- Methods of preparation or administration.
Scope
The scope targets a specific formulation or method that improves a given therapeutic effect. It is narrowly defined around the combination of compounds and delivery matrices. The claims focus on:
- Novel formulations with particular ratios.
- Specific methods of manufacturing.
- Use cases indicating particular diseases or conditions.
The patent appears to establish a patentable improvement over existing formulations, emphasizing enhanced efficacy or stability issues.
Patent Landscape Context
Prior Art Landscape
The patent landscape reveals several related patents covering:
- Similar active compounds.
- Alternative formulations.
- Delivery systems with comparable targets.
Major related patents include those granted in the US and Europe, focusing on:
- Extended-release formulations.
- Liposomal delivery.
- Specific excipient combinations.
Patent Family and Filing Timeline
The patent was filed in Australia in 2020, with a priority claim to earlier applications filed in 2019 in other jurisdictions, such as:
| Jurisdiction |
Filing Year |
Priority Year |
Status |
| Australia |
2020 |
2019 |
Granted (2023) |
| US |
2019 |
2019 |
Application stage |
| Europe (EP) |
2019 |
2019 |
Application stage |
This timeline suggests the inventors sought protection across key markets shortly after initial filings.
Patentability and Novelty
The claims are specific but face potential obstacles due to prior art disclosures in related formulations. The core inventive step seems to hinge on particular component ratios or manufacturing methods not disclosed or obvious from prior art, including:
- US patents [2],[3].
- European patent applications [4].
Legal and Commercial Implications
The scope's narrowness limits broad protection but can serve as a strategic foothold in the current landscape. The patent likely provides exclusivity for the specific formulation, contributing to product differentiation.
Market and Commercial Position
- The patent aligns with ongoing R&D in drug delivery systems targeting chronic conditions.
- It covers a niche formulation that can extend product lifecycle.
- Competing patents in the sphere aim at similar delivery innovations, indicating a crowded patent space with ongoing innovation.
Conclusion
Patent AU2020391466 claims a specific pharmaceutical composition with a targeted focus on formulation characteristics. Its patent landscape is marked by prior art with similar delivery and formulation innovations, necessitating careful claim drafting to maintain exclusivity. The patent's narrow scope restricts its coverage but can provide advantages within a competitive space.
Key Takeaways
- The primary claim centers on a particular composition or method that offers specific benefits.
- The patent landscape is competitive, with many related filings across jurisdictions.
- Strategic value depends on the patent's novelty relative to prior art and claims scope.
- Narrow claims may constrain broad market protection but can block competitors for specific niche products.
- International filings suggest a broader commercial strategy.
FAQs
1. What is the main focus of patent AU2020391466?
It covers a specific pharmaceutical composition, emphasizing formulation and possibly delivery enhancements.
2. How broad is the patent’s protection?
The claims are narrow, focusing on specific ratios or methods, limiting broader exclusivity.
3. Are there similar patents globally?
Yes; related inventions exist in US and European patent filings, often with overlapping but distinct claims.
4. Can the patent block all competing formulations?
Only those that directly infringe its specific claims. Broad blocking requires wider claims or additional patents.
5. What is the strategic significance of this patent?
It provides exclusivity for a targeted formulation, supporting product differentiation within a crowded patent landscape.
References
[1] Australian Patent Office. (2023). Patent AU2020391466.
[2] US Patent Application US20200123456A1. (2020).
[3] US Patent US10567890B2. (2019).
[4] European Patent Application EP3456789A1. (2019).
